<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Quanterix Corporation

    Quanterix Corporation

    Quanterix is a company that is digitizing biomarker analysis with the goal of adva...

    Quanterix is a company that is digitizing bioma...

    Filing Type:    PU
    Arrowhead Pharmaceuticals, Inc.

    Arrowhead Pharmaceuticals, Inc.

    Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by si...

    Arrowhead Pharmaceuticals develops medicines th...

    Filing Type:    PU
    IDEAYA Biosciences, Inc.

    IDEAYA Biosciences, Inc.

    IDEAYA is an oncology-focused precision medicine company committed to the discover...

    IDEAYA is an oncology-focused precision medicin...

    Filing Type:    PU
    Livongo Health, Inc.

    Livongo Health, Inc.

    Livongo Health, Inc. (NASDAQ: LVGO) is a leading Applied Health Signals company em...

    Livongo Health, Inc. (NASDAQ: LVGO) is a leadin...

    Filing Type:    PU
    Illumina, Inc.

    Illumina, Inc.

    A global leader in DNA sequencing and array-based technologies, Illumina is fuelin...

    A global leader in DNA sequencing and array-bas...

    Filing Type:    PU
    Maternova, Inc.

    Maternova, Inc.

    Maternova, Inc. is the trusted resource for cutting edge medical innovations in ne...

    Maternova, Inc. is the trusted resource for cut...

    Amount Raised:    $104,976.00
    Fundraising Status:    EC
    Filing Type:    CF
    Cue Biopharma, Inc.

    Cue Biopharma, Inc.

    Cue Biopharma is an innovative clinical stage immunotherapy company developing a n...

    Cue Biopharma is an innovative clinical stage i...

    Filing Type:    PU
    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy ...

    Atara Biotherapeutics is a leading off-the-shel...

    Filing Type:    PU
    Equillium, Inc.

    Equillium, Inc.

    Equillium is a biotechnology company leveraging deep understanding of immunobiolog...

    Equillium is a biotechnology company leveraging...

    Filing Type:    PU
    Cellectis S.A.

    Cellectis S.A.

    Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune ...

    Cellectis is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    Syndax Pharmaceuticals, Inc.

    Syndax Pharmaceuticals, Inc.

    Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on ...

    Syndax Pharmaceuticals, Inc. is a late-stage bi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.